The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD19 CAR-T cells combined with ibrutinib to induce complete remission in CLL.
 
Saar Gill
Honoraria - Alexion Pharmaceuticals
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents for chimeric antigen receptor T cells for acute myeloid leukemia
 
Noelle V. Frey
Consulting or Advisory Role - Amgen
Research Funding - Novartis
 
Elizabeth O. Hexner
No Relationships to Disclose
 
Simon F. Lacey
Research Funding - Novartis
 
Jan Joseph Melenhorst
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents
 
John C. Byrd
Research Funding - Acerta Pharma; Genentech; Pharmacyclics
 
Susan Metzger
No Relationships to Disclose
 
Taylor Marcus
No Relationships to Disclose
 
Whitney Gladney
No Relationships to Disclose
 
Katherine Marcucci
Research Funding - Novartis (Inst)
 
Wei-Ting Hwang
No Relationships to Disclose
 
Carl H. June
Stock and Other Ownership Interests - Celldex; Immune Design; Tmunity Therapeutics, Inc.
Honoraria - Johnson & Johnson; Novartis; Pfizer
Consulting or Advisory Role - Celldex; Immune Design
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties
 
David L. Porter
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Genentech/Roche (I)
Honoraria - Incyte
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Patent/royalty rights
Travel, Accommodations, Expenses - Immunovative Therapies